Hironori Takagi

64 papers and 969 indexed citations i.

About

Hironori Takagi has authored 64 papers that have received a total of 969 indexed citations. This includes 20 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. The topics of these papers are Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Effects and risks of endocrine disrupting chemicals (8 papers). Hironori Takagi is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Effects and risks of endocrine disrupting chemicals (8 papers) and collaborates with scholars based in Japan and Sri Lanka. Hironori Takagi's co-authors include Masao Hirose, Makoto Shibutani, Chikako Uneyama, Naoya Masutomi and Kyoung‐Youl Lee and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Histochemistry & Cytochemistry

In The Last Decade

Rankless by CCL
2025